Results 261 to 270 of about 10,554,839 (372)
Recurrent BRAF mutations in Langerhans cell histiocytosis.
G. Badalian‐Very+14 more
semanticscholar +1 more source
ABSTRACT Disruptions in circadian rhythm, partly controlled by the hormone melatonin, increase the risk of type 2 diabetes (T2D). Accordingly, a variant of the gene encoding the melatonin receptor 1B (MTNR1B) is robustly associated with increased risk of T2D.
Tania Singh+14 more
wiley +1 more source
Metastatic pheochromocytoma complicated with Langerhans cell histiocytosis: a case report. [PDF]
Dai D, Xie J.
europepmc +1 more source
Isolation and Preliminary Biochemical Characterization of the Human Epidermal Langerhans Cell
J.M. Gommans+4 more
openalex +1 more source
This is the first interview study exploring the perspectives of transplanted adolescents on decision‐making regarding transplantation, and it shows that they want to be part of decision‐making at different levels of involvement. ABSTRACT Background In pediatrics, the triadic relationships between the adolescent, parents, and healthcare providers, as ...
Alana Vallo‐Sacchettini+4 more
wiley +1 more source
Langerhans cell histiocytosis of the jaw: clinical analysis of 68 cases. [PDF]
Li J, Wu H, Wang Z, Han J, Liu J, Han B.
europepmc +1 more source
Modernizing U.S. Sunscreen Regulations: How Newer Filters Can Improve Public Health
ABSTRACT Background Skin cancer is the most common cancer in the United States, with over 5 million cases diagnosed annually. Despite being largely preventable, incidence rates continue to rise, largely due to inadequate protection from ultraviolet (UV) radiation, the primary environmental cause of skin cancer.
Clayton Wade Turner, Leslie Torgerson
wiley +1 more source
Disease response criteria in Langerhans cell histiocytosis: a global view. [PDF]
Buhtoiarov IN, Minkov M, Vali R, Abla O.
europepmc +1 more source
ABSTRACT Background Narrowband‐ultraviolet B (NB‐UVB) phototherapy is an effective treatment for psoriasis in patients who have failed topical regimens or those who desire to avoid systemic treatment. Despite its regular use in non‐white individuals, NB‐UVB treatment response for psoriasis in skin of color (SOC) has not been systematically reviewed ...
Megan Hauptman+3 more
wiley +1 more source